Findings from the NATALEE trial show that the combination of Kisqali and an aromatase inhibitor resulted in disease-free ...

Kisqali has been FDA-approved with an aromatase inhibitor as postsurgical treatment for some with early breast cancer at a ...

Keytruda plus chemo has been approved for unresectable advanced or metastatic malignant pleural mesothelioma based on ...

Vonjo was also shown to improve overall survival in patients with myelofibrosis treated with Vonjo in the real-world setting.

Imfinzi with monalizumab and ceralasertib showed promising long-term benefits in advanced NSCLC, but no other combinations ...

I am still struggling to navigate the intrusive questions of well-meaning strangers 17 years after surviving inflammatory ...

Treatment with Brukinsa may lower the rates of switching therapies compared with Calquence and Imbruvica in chronic ...

Patients with muscle-invasive bladder cancer who were treated with presurgical chemotherapy may have a 55% lower risk of ...

In patients with HR-positive breast cancer who recently gave birth, breastfeeding is OK during a break from receiving hormone ...

An artificial intelligence model was shown to predict tumor mutation burden in lung cancer and other diseases.

ESMO Congress, an expert explained how Nubeqa may reduce fatigue-related side effects in metastatic hormone-sensitive ...

Before receiving treatment for acute myeloid leukemia, I made it a point to take advantage of all the resources that were ...